Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes

Chest

Volumn 143, Issue 5, 2013, Pages 1226-1234

  Lanspa, Michael J ^a,b   Hirshberg, Eliotte L ^a,b   Phillips, Gregory D ^a   Holmen, John ^b   Stoddard, Gregory ^a   Orme, James ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGE; AGED; APACHE; ARTICLE; BLOOD GLUCOSE MONITORING; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 84875598271     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2072     Document Type: Article

References (40)

1. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345(19):1359-1367.
2. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-827.
3. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on4-years survival, dependency on medical care, and quality-of-life. Eur Heart J. 2006;27(22):2716-2724. (Pubitemid 44729874)
4. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5): 449-461. (Pubitemid 43200296)
5. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10): 1738-1748.
6. Brunkhorst FM, Engel C, Bloos F, et alGerman Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358(2):125-139.
7. Finfer S, Chittock DR, Su SY, et al NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13): 1283-1297.
8. Cefalu WT. Mortality and glycemic targets in the intensive care unit: another paradigm shift? Diabetes. 2009;58(7): 1469-1470.
9. Bellomo R, Egi M. What is a NICE-SUGAR for patients in the intensive care unit? Mayo Clin Proc. 2009;84(5):400-402.
10. Juneja R, Roudebush CP, Nasraway SA, et al. Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time. Crit Care. 2009;13(5):R163.
11. Krinsley JS, Meyfroidt G, van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care. 2012;15(2):151-160.
12. van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151-3159. (Pubitemid 44923655)
13. Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg. 2006;18(4):317-325. (Pubitemid 46464513)
14. Egi M, Bellomo R, Stachowski E. et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36(8):2249-2255.
15. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008; 36(11):3008-3013.
16. Egi M. Bellomo R. Stachowski E. French CJ. Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2): 244-252. (Pubitemid 44148168)
17. Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C; ANZICS CORE Management Committee. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13(3):R91.
18. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3): 838-842.
19. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154(4):260-267.
20. Moghissi ES, Korytkowski MT, DiNardo M, et al American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4): 353-369.
21. Morris AH, Orme J Jr, Truwit JD, et al. A replicable method for blood glucose control in critically Ill patients. Crit Care Med. 2008;36(6):1787-1795.
22. Thompson BT, Orme JF, Zheng H, et al Reengineering Critical Care Clinical Research Investigators. Multicenter validation of a computer-based clinical decision support tool for glucose control in adult and pediatric intensive care units. J Diabetes Sci Tech. 2008;2(3):357-368.
23. Garber AJ, Moghissi ES, Bransome ED Jr, et al American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(suppl2):4-9.
24. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10(suppl2):71-80.
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829. (Pubitemid 15250137)
26. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
27. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994; 47(11):1245-1251. (Pubitemid 24361532)
28. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc. 2005;80(12):1558-1567. (Pubitemid 41747057)
29. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med. 2010;38(4):1021-1029.
30. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Tech. 2009; 3(6):1292-1301.
31. Klip A, Tsakiridis T, Marette A, Ortiz PA. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J. 1994;8(1):43-53. (Pubitemid 24047410)
32. Huang JP, Huang SS, Deng JY, Hung LM. Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats. J Biomed Sci. 2009;16 :77.
33. Weekers F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144(12):5329-5338. (Pubitemid 37476061)
34. Ling PR, Mueller C, Smith RJ, Bistrian BR. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism. 2003;52(7):868-874. (Pubitemid 36949550)
35. Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA, Willems JL, Van der Hoeven JG. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med. 2008;36(11):3062-3066.
36. Inzucchi SE. Siegel MD. Glucose control in the ICU-how tight is too tight? N Engl J Med. 2009;360(13):1346-1349.
37. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007; 35(10):2262-2267. (Pubitemid 47476221)
38. Kosiborod M, Inzucchi SE, Goyal A, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301(15):1556-1564.
39. Kagansky N, Levy S, Rimon E, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med. 2003;163(15):1825-1829. (Pubitemid 36960932)
40. Finfer S, Liu B, Chittock DR, et al NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367(12):1108-1118.